📊 Antibody–drug conjugates outperform chemotherapy in EGFR-TKI-resistant NSCLC, according to this Bayesian network meta-analysis.
What does this mean for post-TKI treatment strategies?
🔗 Read now: buff.ly/mBdISSD
#Oncology #NSCLC #LungCancer #ADCs #CancerResearch
